| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 103.691 | 111.166 | 212.739 | 86.768 |
| Total Income - EUR | - | - | - | - | - | - | 103.858 | 198.908 | 212.744 | 87.898 |
| Total Expenses - EUR | - | - | - | - | - | - | 86.478 | 254.081 | 227.681 | 146.249 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 17.381 | -55.173 | -14.937 | -58.352 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 14.151 | -58.059 | -14.937 | -58.352 |
| Employees | - | - | - | - | - | - | 0 | 1 | 0 | 0 |
Check the financial reports for the company - Pharmagenix Ai S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 137 | 954 | 4.376 | 3.834 |
| Current Assets | - | - | - | - | - | - | 31.934 | -1.477 | 12.068 | 28.781 |
| Inventories | - | - | - | - | - | - | 895 | 0 | 0 | 808 |
| Receivables | - | - | - | - | - | - | -3.574 | -5.620 | 8.285 | 3.044 |
| Cash | - | - | - | - | - | - | 34.613 | 4.143 | 3.782 | 24.929 |
| Shareholders Funds | - | - | - | - | - | - | 14.191 | -57.612 | -73.731 | -94.376 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 17.880 | 57.185 | 90.282 | 127.122 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4645 - 4645" | |||||||||
| CAEN Financial Year |
4645
|
|||||||||
Comments - Pharmagenix Ai S.r.l.